Draft April 13, 2011
Global Academic Programs 2011 Conference
May 31st – June 2, 2011
Hickey Auditorium and Anderson Conference Hall
Program Agenda
Tuesday, May 31, 2011
8:00 – 8:05 AM
8:05 – 9:15 AM
Opening Address
Oliver Bogler, Ph.D, Professor of Neurosurgery
Vice President, Global Academic Programs
Keynote Address
Tumor Resequencing
Richard Gibbs, Ph.D., Director and Wofford Cain Professor
BCM-Human Genome Sequencing Center
Department of Molecular and Human Genetics
Baylor College of Medicine
Large-scale Sequencing of Tumors in Hospital AC Camargo
Emmanuel Dias-Neto, Ph.D.
Head, Medical Genomics and Bioinformatics
AC Camargo Cancer Hospital – Sao Paulo, Brazil
Genomic Sequencing of Human Primary Brain Tumors
Daniel Patrick Cahill, M.D., Ph.D.
Assistant Professor, Neurosurgery
UT M.D. Anderson Cancer Center
Tmprss2: Erg Gene-Fusion Promotes Epithelial to
Mesenchymal Transition in Immortalized Human Prostate
Transition Epithelial Cells
Raanan Berger, M.D., Ph.D.
Senior Oncologist
Sheba Medical Center – Tel Hashomer, Israel
High-Throughput Sequencing-Based Small RNA Identification
for Biomarker Discovery in Oral Squamous Cell Carcinoma
Patricia Severino, Ph.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
9:15 – 10:30 AM
Biomarkers and Gene Expression
Session Chair, Kenneth D. Aldape, M.D.
Professor, Pathology
UT M.D. Anderson Cancer Center
1
Draft April 13, 2011
IDH1
Andreas Von Deimling, M.D.
German Cancer Research Center (DKFZ) – Heidelberg, Germany
Molecular Aspects of Breast Cancer: Insights From Gene
Expression Studies
Dirce Carraro, Ph.D.
Coordinator of Nucleic Acid Bank
Head, Laboratory of Molecular Biology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
TP53 Mutations as Biomarkers for Cancer Detection,
Prognosis and Therapy
Pierre Hainaut, Ph.D.
Head, Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
Pharmacogenomic Biomarker Development in Gastric Cancer
Sun Young Rha, M.D.
Yonsei Cancer Center – Seoul, Korea
The Wilms’ Tumor Initiating Cell Is An NCAM Cell Enriched
for ALDH1 Activity and Possessing Renal Stem Cell
Characteristics That Can Be Targeted in Vivo
Benjamin Dekel, M.D.
Professor
Sheba Medical Center – Tel Hashomer, Israel
Oncogenetics at Albert Einstein Hospital: Patient Care,
Education and Research
Fernanda Teresa de Lima, M.D., Ph.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
10:30 – 10:45 AM
Coffee Break
10:45 – 12:30 PM
Drug and Technology Research and Development
Session Chair, Garth Powis, DPHIL
Professor and Chair, Experimental Therapeutics
UT M.D. Anderson Cancer Center
*Young Investigator Travel Award*
MRI for Depiction of Subtle BBB Opening in Glioblastoma
Multiforme Patients
Yael Mardor, M.D.
Sheba Medical Center – Tel Hashomer, Israel
2
Draft April 13, 2011
KLOTHO: From Hormone to Novel Cancer Therapy
Ido Wolf, M.D.
Senior Oncologist
Sheba Medical Center – Tel Hashomer, Israel
STIL Regulates Mitotic Entry and Centrosomal Formation
Through Regulation of the CHFR Tumor Suppressor Protein
Shai Izraeli, M.D.
Associate Professor
Sheba Medical Center – Tel Hashomer, Israel
Good Clinical Practice (GCP) Center in China
Yuanki Shi, M.D.
Professor and Vice President
Chinese Academy of Medical Sciences (CAMS) Cancer Institute &
Hospital – Beijing, China
*DKFZ SINF Award*
Intensity modulated particle therapy
Uwe Oelfke, Ph.D.
Medical Physics, Radiation Therapy
German Cancer Research Center (DKFZ) – Heidelberg, Germany
Radhe Mohan, Ph.D.
Professor, Radiation Physics – Patient Care
UT M.D. Anderson Cancer Center
12:30 – 2:00 PM
Lunch
GAP Business Meeting (all are invited)
o GAP Network and GAP Connect
o Sister Institution Network Fund (SINF)
o GAP 2012 Conference (Oslo, Norway)
Hickey Auditorium
2:00 – 4:30 PM
Global Clinical Trials Research
Session Chair, Hagop M. Kantarjian, M.D.
Professor and Chair, Leukemia
Associate Vice President for Clinical Research, GAP
2:00 – 2:15 PM
New Drugs, Pathways, Shared Protocols, Infrastructure
Hagop M. Kantarjian
2:15 – 2:30 PM
Inflammatory Breast Cancer Registry
Other site tbc
Other person tbc
Ricardo Alvarez, M.D.
3
Draft April 13, 2011
2:30 – 2:45 PM
Trial title tbc
Chinese University of Hong Kong – Hong Kong, China
Anthony Chan, M.D.
Kian Ang, M.D.
2:45 – 3:00 PM
International Validation Study of Post-Chemotherapy Viable
NSGCT
Institute Gustave Roussy – Villejuif, France
Karim Fizazi, M.D.(tbc)
Lance Pagliaro, M.D.
3:00 – 3:15 PM
Clinical Trials: Starting a Local Network and Collaboration
with M.D. Anderson Cancer Center
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Oren Smaletz, M.D.
MDACC person tbc
3:15 – 3:30 PM
Development of IND Based International Investigator Breast
Cancer Clinical Trials
Tokyo Oncology Consortium – Tokyo, Japan
Teruo Yamauchi, M.D.
Naoto Ueno, M.D. Ph.D.
3:30 – 3:45 PM
MDACC / INEN Prior and Current Breast Cancer Trials
National Cancer Institute of Peru – Lima, Peru
Tatiana Vidaurre, M.D.
Vicente Valero, M.D.
3:45 – 4:00 PM
Phase I Study of Ofatumumab for Purging in Large
Cell Lymphoma
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Clinica Alemana – Santiago, Chile
Nelson Hamerschlak, M.D.,Ph.D
Alejandro Majlis, M.D.
Marcos de Lima, M.D.
4:00 – 4:15 PM
Conservative Surgery for Women with Low-risk, Early Stage
Cervical Cancer
Clinica Alemana – Santiago, Chile
CA person to be determined
Kathleen Schmeler, M.D.
4:15 – 4:30 PM
A Phase III Randomized Clinical Trial of Laparoscopic or
Robotic Radical Hysterectomy versus Abdominal Radical
Hysterectomy in Patients with Early Stage Cervical Cancer
4
Draft April 13, 2011
Instituto de Cancerologia Las Americas – Medellin, Colombia
Rene Pareja, M.D.
Pedro Ramirez, M.D.
A Vision for the Future - Multimedia Structured Reporting
David Vinning, M.D.
Professor, Diagnostic Radiology
UT M.D. Anderson Cancer Center
4:30 – 5:00 PM
Collaboration Discussion
5:00 – 5:30 PM
Welcome Address
John Mendelsohn, M.D.
President
UT M.D. Anderson Cancer Center
5:30 – 7:30 PM
Welcome Reception
Anderson Conference Hall
Wednesday, June 1, 2011
8:00 – 10:00 AM
Plenary Session - Signal Transduction
Mien-Chie Hung, Ph.D.
Professor and Chair, Molecular and Cellular Oncology
UT M.D. Anderson Cancer Center
Cancer Biomarkers in Neuro-Oncology
Rui Reis, Ph.D.
Director of Research and Coordinator of Molecular Oncology
Research Lab
Barretos Cancer Hospital – Barretos, Brazil
Title to be decided
Hideyuki Saya, M.D.,Ph.D.
Professor, Division of Gene Regulation
Institute for Advanced Medical Research(IAMR)
School of Medicine, Keio University – Tokyo, Japan
Endocytic Protein: Master Regulator of Cell Signalling
Guoguang Ying, Ph.D.
Professor, Deputy Director
Tianjin Cancer Research Institute – Tianjin, China
Epigenetic Regulation of Neuron Differentiation From
Mesenchymal Stem Cells By Polycomb Group Protien EZH2
Alan Yung-Luen Yu, Ph.D.
5
Draft April 13, 2011
Associate Research Fellow, Center for Molecular Medicine
China Medical university Hospital – Taichung, Taiwan
8:00 – 10:00 AM
Sister Institution Network Fund (SINF) Program Committee
Meeting (only your designated SINF program committee member
can attend – this a closed meeting)
10:00 – 10:15 AM
Coffee Break
Simultaneous Break-Out Sessions
10:15 – 1:00 PM
Frontiers In Gastrointestinal and Hepatobiliary Cancers
Session Chair, Lopa Mishra, M.D.
Professor and Chair, Gastroenterology, Hepatology & Nutrition
UT M.D. Anderson Cancer Center
Molecular Targets and Opportunities: Tumor Initiating Stem
Cells In Gastrointestinal and Hepatocellular Cancer
Lopa Mishra, MD
Chair and Professor, Department of Gastroenterology,
Hepatology, & Nutrition
The University of Texas MD Anderson Cancer Center
Education and Imaging in Liver and Pancreatic Cancers in
India at a GEMS Institute
C.E. Eapen, MD
Professor of Gastroenterology and Hepatology
Christian Medical College, Vellore, India
Hepatocellular Cancer: A Global Perspective
Shiv Sarin, MD
Chairman of the Medical Council of India (MCI)
Professor and Head, Department of Hepatology, & Director,
Institute of Liver and Biliary Sciences (ILBS)
GB Pant Hospital, New Delhi, India
Biliary Cancers: New Advances
Ivan Roa, MD
Chief, Department of Pathology
Clinica Alemana de Santiago – Santiago, Chile
Colon Cancer – High Risk Cancer Registry and Advances in
FAP
Patrick Lynch, JD, MD
Professor, Department of Gastroenterology, Hepatology, &
Nutrition
6
Draft April 13, 2011
The University of Texas MD Anderson Cancer Center
New Horizons in Cancer Prevention – for GI and
Hepatobiliary Cancers
Powel Brown, MD, PhD
Chair and Professor, Clinical Cancer Prevention
The University of Texas MD Anderson Cancer Center
Laparasocopy Versus Robotic TME for Rectal Cancer: A
Prospective Randomized Trial
Antonio Luiz de Vasconcellos Macedo, M.D.
General Surgeon, President, Oncology Council
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Enigmatic of Low Incidence of GI Cancers in Indians
Mohandas Mallath, M.D.
Convener, GI Cancer – Disease Management Group and Director,
Centre for Epidemiology
Tata Memorial Centre – Mumbai, India
Response Predictors for Neoadjuvant Treatment in Rectal
Cancer
Samuel Aguiar Jr, M.D., Ph.D.
Surgical Oncology
AC Camargo Hospital – Sao Paulo, Brazil
Chemoradiotherapy For Colorectal Cancer: Results From
Prospective Randomized Nordic Trials
Kjell Magne Tveit, M.D.
Professor and Head of Department of Oncology
Oslo University Hospital – Olso, Norway
Surgical Treatment of Hepatocellular Carcinoma
Qiang Li, M.D.
Vice President
Tianjin Medical University Cancer Institute – Tianjin, China
Collaboration Discussion
10:15 – 12:30 PM
Breast Cancer
Session Chair, Banu K. Arun, M.D.
Professor, Breast Medical Oncology
UT M.D. Anderson Cancer Center
The Application of a Modified Gail Model in Estimating the
Risk for Developing Breast Cancer Among Jordanian Women
Luna Al-Zaru, M.D.
7
Draft April 13, 2011
Director, Office of clinical Research and Cancer Registry
King Hussein Cancer Center – Amman, Jordan
The Glucagon-like Peptide (GLP)-1 and Exendin-4: Activators
of cAMP and Novel Growth Inhibitors of Breast Cancer Cells
Tami Rubinek, Ph.D.
Sheba Medical Center – Tel Hashomer, Israel
Higher Expression of Androgen Receptor as a Significant
Predictor for Better Endocrine-responsiveness in Estrogen
Receptor-Positive Breast Cancers
Se-ho Park, M.D., Ph.D.
Surgery
Yonsei University Medical Center – Seoul, South Korea
Effects of An mTOR Inhibitor RAD001 on Human Breast
Cancer Stem Cells In Vitro and In Vivo
Jin Zhang, M.D.
Director, Breast Cancer Center
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
Breast Cancer Patient Satisfaction With Reconstruction: Arab
Women Experience
Firas F. AL-Ahmad, MD, MRCS
Surgical Oncology Fellow, Department of Surgery
King Hussein Cancer Center – Amman, Jordan
Collaboration Discussion
10:15 – 12:30 PM
Hematologic Malignancies
Session Chair, Marcos J. de Lima, M.D.
Professor, Stem Cell Transplantation
UT M.D. Anderson Cancer Center
Implications of Microenvironment Interactions in Multiple
Myeloma (MM) and Chronic Lymphocytic Leukemia (CLL):
The Role of CXCR4/CXCL12 Chemokine Pathway
Katia Beider, Ph.D.
Sheba Medical Center – Tel Hashomer, Israel
Oral or IV BFLU as a Conditioning Regimen for Myeloid
Diseases at Albert Einstein
Fabio Kerbauy, M.D.
Hematology
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
8
Draft April 13, 2011
Azacitidine 100mg Fixed Daily Dose for the Treatment and
Retreatment of Patients with Myelodysplastic Syndrome and
Acute Myeloid Leukemia
Su-Peng Yeh, M.D.
Associate Professor
China Medical University Hospital – Taichung, Taiwan
A Randomised, Open-Label, Multicentre Phase III Study of
the Combination of Rituximab, Cyclophosphamide,
Doxorubicin, VELCADE, and Prednisone (VcRCAP) or
Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and
Prednisone (RCHOP) in Patients With Newly Diagnosed
Mantle Cell Lymphoma Who Are Not Eligible for a Bone
Marrow Transplant
Huanqing Wang, M.D.
Director, Lymphoma Department
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
*DKFZ SINF Award*
Deciphering the Role of Non-coding RNA in Chronic
Lymphocytic Leukemia
Thorsten Zenz, Translational Oncology
German Cancer Research Center (DKFZ) – Heildelberg, Germany
George A. Calin, M.D., Ph.D.
Associate Professor, Experimental Therapeutics
UT M.D. Anderson Cancer Center
Research Profile for the Lymphoma Program at the
Norwegian Radium Hospital
Harald Holte, M.D.
Professor,
Norwegian Cancer Consortium – Oslo, Norway
Title to be determined
Jose Francisco Tomas, M.D.
Medical Director and Chief of Hematology
Centro Oncologico M.D. Anderson International Espana –
Madrid, Spain
R-ESHAP As Salvage Therapy In Chinese Patients With
Relapsed Or Refractory Diffuse Large B-cell Lymphoma: A
Prospective Phase II Study
Kai Xue, M.D.
??
9
Draft April 13, 2011
Fudan University Cancer Hospital – Shanghai, China
Collaboration Discussion
10:15 – 12:30 PM
Pain and Supportive Care
Session Chairs
Thomas W. Feeley, M.D.
Professor and Division Head, Anesthesiology and Critical Care
UT M.D. Anderson Cancer Center
Eduardo Bruera, M.D.
Professor and Chair, Palliative Care & Rehabilitation Medicine
Pain Management Experience at King Hussein Cancer Center
(KHCC)
Hussein Abu Khudair, M.D.
Chairman, Department of Anesthesia & Pain Management
King Hussein Cancer Center – Amman, Jordan
Pain Management at M.D. Anderson Cancer Center
Larry C. Driver, M.D.
Chair Ad Interim and Professor, Pain Medicine
UT M.D. Anderson Cancer Center
Supportive and Palliative Care at M.D. Anderson Cancer
Center
David Hui, M.D.
Assistant Professor, Palliative Care and Rehabilitation Medicine
UT M.D. Anderson Cancer Center
Collaboration Discussion
10:15 – 12:30 PM
Tumor Resequencing Workshop
(To be held at the Genome Center at Baylor College of Medicine)
David A. Wheeler, Ph.D.
Associate Professor, Human Genome Sequencing Center
Department of Molecular & Human Genetics
Baylor College of Medicine
Collaboration Discussion
12:30 – 2:00 PM
Lunch at Trevisio
Directors’ Luncheon
2:00 – 3:45 PM
Plenary Session – Personalized Medicine
10
Draft April 13, 2011
Evolution of Personalized Medicine In Non-Small Cell Lung
Cancer (NSCLC)
Edward S. Kim, M.D., Associate Professor
Thoracic / Head & Neck Medical Oncology
UT M.D. Anderson Cancer Center
Talk title tbc
Thomas Tursz, M.D.
Former Director
Institute Gustave Roussy – Villejuif, France
The WIN Symposium
Vladimir Lazar, M.D., Ph.D.
Institute Gustave Roussy - Villejuif, France
Clinical Responses Using Adoptive Transfer of Young Tumor
Infiltrating Lymphocytes in Metastatic Melanoma Patients
Michal J. Besser, Ph.D.
Head of Clinical Lab
Sheba Medical Center – Tel Hashomer, Israel
3:30 – 3:45 PM
Coffee Break
3:45 – 5:15 PM
Simultaneous Break-Out Sessions
3:45 – 5:15 PM
Genitourinary Malignancies
Session Chair, Deborah Kuban, M.D.
Professor, Radiation Oncology
UT M.D. Anderson Cancer Center
The Proton Therapy Center at M.D. Anderson Cancer Center
Speaker tbc
Associate Professor, Radiation Oncology
UT. M.D. Anderson Cancer Center
Pentafecta: A New Concept for Reporting Outcomes of RobotAssisted Laparoscopic Radical Prostatectomy
Rafael Ferreira Coelho, M.D.
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
Ethnic Differences in Treating mRCC with Targeted Agents
Sun Young Rha, M.D.
??
Yonsei Cancer Center
11
Draft April 13, 2011
Prognostic Molecular Markers in Non-Muscle Invasive
Bladder Cancer: Results and Perspectives
Mario Fernandez, M.D.
Urology
Clinica Alemana – Santiago, Chile
*Young Investigator Travel Award*
Association of Polymorphisms and Expression of ERCC1 and
XPA With The Response of Patients With Testicular Germ
Cell Tumors Treated With Cisplatin
Julia R. Mendoza Perez, M.D.
National Cancer Institute (INCan) – Mexico City, Mexico
Collaboration Discussion
3:45 – 5:15 PM
Head & Neck/Thoracic Cancers
Session Chair, Merrill S. Kies, M.D.
Professor, Thoracic/Head & Neck Medical Oncology
UT M.D. Anderson Cancer Center
Epigenetic Markers in Saliva for Diagnosis and Prognosis of
Head and Neck Cancer Patients
Andre Lopes Carvalho, M.D., Ph.D.
Research Director, Chief, Head & Neck Cancers
Barretos Cancer Hospital – Barretos, Brazil
AC Camargo Hospital Experience in the Treatment of Oral
Cancer
Luiz Paulo Kowalski, M.D., Ph.D.
Director, Head & Neck Surgery and Otorhinolaryngology
AC Camargo Cancer Hospital – Sao Paulo, Brazil
The Susceptibility Genes of NasoPharyngeal Carcinoma
Jin-Xin Bei, M.D.
Associate Professor
Sun Yat-Sen University Cancer Center – Guangzhou, China
Novel Therapeutic Strategies in Nasopharyngeal Cancer
Herbert Loong, M.D.
Honorary Clinical Tutor
Chinese University of Hong Kong – Hong Kong, China
Lung Cancer in Brazil: Characteristics & Challenges
Ricardo Sales dos Santos, M.D.
Head, Minimally Invasive Thoracic Surgery
12
Draft April 13, 2011
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
The Cyberknife Treatment for Early Stage Lung Cancer
Yuan Zhiyong, M.D.
Director, Radiotherapy Department
Tianjin Medical University Cancer Institute and Hospital –
Tianjin, China
Collaboration Discussion
3:45 – 5:15 PM
Gynecologic Malignancies
Session Chair, Pedro Tomas Ramirez, M.D.
Associate Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
*Young Investigator Travel Award*
The Biphasic Role of NF-kB in Tumor Progression and
Chemoresistance of Ovarian Cancer
Gong Yang
Fudan University Shanghai Cancer Center – Shanghai, China
3:45 - 3:50 PM
Introduction
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
3:50 - 4:10 PM
Phase III International Randomized Trial of Open Versus
Minimally Invasive Surgery for Cervical Cancer
Pedro T Ramirez, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
4:10 - 4:20 PM
Prospective Study of Conservative Surgery for Early Stage
Cervical Cancer
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
4:20 – 4:30 PM
A Pilot Study Using Optimal Imaging for Cervical Cancer
Screening in Brazil
Jose Humberto Fregnani, M.D.
Chief, Gynecologic Oncology
Barretos Cancer Hospital – Barretos, Brazil
13
Draft April 13, 2011
4:30 – 4:40 PM
Challenges of Prospective, International Multi-Institutional
Trials
Kathleen M. Schmeler, M.D.
Assistant Professor, Gynecologic Oncology
UT M.D. Anderson Cancer Center
4:40 – 5:00 PM
Collaborations with MD Anderson: The Collaborator's
Perspective
Rene Pareja, M.D., Gynecology
Instituto de Cancerologia IDC Las Americas – Medellin, Colombia
David Cantu, M.D., Gynecology
Instituto Nacional de Cancerologia – Mexico City, Mexico
Aldo Lopez, M.D., Gynecology
Instituto Nacional de Enfermedades Neoplasicas – Lima, Peru
5:00 – 5:15 PM
Collaboration Discussion
5:15 – 7:00 PM
Wine and Cheese Reception – Hickey Foyer
Poster Session (keep posters up thru next morning)
Thursday, June 2, 2011
8:00 – 10:30 AM
Plenary Session – Cancer Prevention
Ernest Hawk, M.D., VP, Cancer Prevention & Population Sciences
UT M.D. Anderson Cancer Center
8:00 – 8:15 AM
Challenges In Cancer Prevention Programs: Resource
Constrained Settings
Surenda S. Shastri, M.D.
Head, Preventive Oncology
Tata Memorial Centre – Mumbai, India
8:15 – 8:30 AM
Is Community Intervention in Breast Cancer Screening in
Brazil Feasible?
Edmundo Mauad, M.D., Ph.D.
Medical Director and Head of Prevention
Barretos Cancer Hospital – Barretos, Brazil
8:30 – 8:45 AM
HPV Vaccination: Preliminary Results of a School-Based
Project Designated b y the Barretos Cancer Hospital, Brazil
Jose Humberto Fregnanai, M.D., Ph.D.
Head, Gynecologic Oncology
Barretos Cancer Hospital – Barretos, Brazil
14
Draft April 13, 2011
8:45 – 9:00 AM
International Networks for Global Prevention Research: The
Next Generation
Pierre Hainaut, Ph.D.
Head of Molecular Carcinogenesis
International Agency for Research on Cancer – Lyon, France
9:00 – 9:15 AM
Coffee Break
9:15 – 9:30 AM
Smoking Prevention in Youth: A Spectrum of Intervention
Approaches
Karen Sue Calabro, Ph.D.
Population Sciences Fellow
UT M.D. Anderson Cancer Center
Alexander V. Prokhorov, M.D., Ph.D.
Professor and Director, Tobacco Outreach Education Program
Director, eHealth Technology Program
Department of Behavioral Science
Division of Cancer Prevention and Population Sciences
UT M.D. Anderson Cancer Center
9:30 – 9:45 AM
The Framework Convention Treaty and Tobacco Policies
Around the World
Joel S. Dunnington, M.D.
Professor, Diagnostic Radiology, Director, GI Radiology
UT M.D. Anderson Cancer Center
9:45 – 10:00 AM
Smoking Cessation in Cancer Patients and Other Chronic
Disease Populations
Ellen R. Gritz, Ph.D.
Professor and Chair, Behavioral Science
UT M.D. Anderson Cancer Center
10:00 – 10:30 AM
Collaboration Discussion
10:30 – 10:45 AM
Coffee Break
10:45 – 12:30 PM
Simultaneous Break–Out Sessions
Survivorship
Session Chair, Michele Forman, PH.D.
Professor, Epidemiology
UT M.D. Anderson Cancer Center
Developing a Cancer Survivorship Programme at Tata
Memorial Hospital Using ACT (After Completion Therapy)
15
Draft April 13, 2011
Clinic for Long Term Survivors of Childhood Cancer as a
Model
Purna A. Kurkure, M.D.
Professor & Head of Pediatric Oncology, Coordinator, ACT Clinic
Tata Memorial Hospital – Mumbai, India
The Problems Caused By Curing Testicular Cancer (TC) and
Survivorship
Sophie Fossa, M.D.
Professor
The Radium Hospital – Oslo, Norway
Fertility After Childhood Cancer: A Registry-based Study
Milada Cvancarova, M.Sc.
Statistician
The Radium Hospital – Oslo, Norway
Title to be determined
Guadalupe Palos, MSW, DRPH, BS, LMSW, RN (tbc)
Manager, Clinical Protocol Administration, Cancer Survivorship
UT M.D. Anderson Cancer Center
Collaboration Discussion
10:45 – 12:30 PM
International Perspective on Integrative Oncology
Session Chair, Lorenzo Cohen, Ph.D.
Professor, General Oncology
UT M.D. Anderson Cancer Center
Chinese Medicine in Oncology: Clinical Care, Research and
International Collaboration
Zhiqiang Meng, M.D.
Department of Integrative Oncology
Fudan University Cancer Center Hospital – Shanghia, China
Holistic Dimensions of Yoga for Breast Cancer: An Update on
Research
H.R. Nagemdra
R. Nagaratna
SVYASA Yoga University – Bangalore, India
Integrative Medicine Research: Mind and Body Research –
Challenges and Opportunities
Paulo de Tarso Lima, M.D.
Integrative and Complementary Medicine
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
16
Draft April 13, 2011
Collaboration Discussion
10:45 – 12:30 PM
Global Challenges and Opportunities Facing Women
Oncologists and Cancer Researchers: A Conversation
Elizabeth L. Travis, Ph.D., FASTRO
Associate VP, Women’s Faculty Programs
UT M.D. Anderson Cancer Center
10:45 – 12:30 PM
International Patient Referrals
Lyle D. Green, MBA
Associate Vice President, Physician Relations
UT M.D. Anderson Cancer Center
12:30 – 2:00 PM
Lunch
Hickey Auditorium Foyer
2:00 – 4:30 PM
Simultaneous Break-Out Sessions
2:00 – 4:30 PM
Pediatrics
Session Chair, Cesar Nunez, M.D.
Assistant Professor, Pediatrics – Patient Care
UT M.D. Anderson Cancer Center
Retrospective Analysis of Pediatric Anaplastic Lymphomas
Or
Treatment of Recurrent Refractory Retinoblastomas
Vicente Odone Filho, M.D., Ph.D.
Pediatrics
Hospital Israelita Albert Einstein – Sao Paulo, Brazil
*DKFZ SINF Award*
Genetic Modification of T Cells for Human Application
Cristof von Kalle, M.D.
Translational Oncology
National Center for Tumor Diseases (NCT), German Cancer
Research Center (DKFZ) – Heidelberg, Germany
Laurence Cooper, M.D., Ph.D.
Associate Professor, Pediatrics – Patient Care
UT M.D. Anderson Cancer Center
Collaboration Discussion
2:00 – 4:30 PM
Epigenetics
17
Draft April 13, 2011
Session Chair, Sharon Dent, Ph.D.
Professor and Chair, Molecular Carcinogenesis
UT M.D. Anderson Cancer Center
Breast Cancer Epigenomics: Evidence for “Epigenetic
Switching” in Breast Cancer Cells Using Next Generation
Sequencing Technologies
Einav Nili Gal-Yam, M.D., Ph.D.
Clinical Oncologist & Cancer Epigenetics Specialist
Sheba Medical Center – Tel Hashomer, Israel
Collaboration Discussion
2:00 – 4:30 PM
Micrometastasis
Session Chair, James Reuben, Ph.D., MBA
Professor, Hematopathology – Research
UT M.D. Anderson Cancer Center
Translating Human Breast Cancer Stem Cell Biology Into The
Clinic
Wendy A. Woodward, MD, PhD
Assistant Professor, Division of Radiation Oncology
UT MD Anderson Cancer Center
The Detection of Circulating Tumor Cells in the Peripheral
Blood of Patients With Breast Cancer Using Real-time Reverse
Transcript-polymerase Chain Reaction for Cytokeratin 19
Soohyeon Lee, M.D.
Medical Oncology
Yonsei University Medical Center – Seoul, South Korea
Molecular Detection of Micrometastases In Sentinel Lymph
Nodes Isolated From Colon Cancer Patients By An Ex Vivo
Approach
Oddmund Nordgard, Ph.D.
Senior Molecular Biologist, Department of Hematology and
Oncology
Stavenger University Hospital – Stavanger, Norway
Detection of Minimal Residual Disease In Bone Marrow, Blood
And Plasma From Early Breast Cancer Patients Using mRNA
and microRNA Markers
Kjersti Tjensvoll, Ph.D.
Molecular Biologist, Department of Hematology and Oncology
Stavenger University Hospital – Stavanger, Norway
18
Draft April 13, 2011
Diagnosis and Prognosis of Pancreatic Cancer By a Novel
Serum Micro RNA Expression Profile-based Biomarker
Yi Ba, MD, PhD
Director, GI Medical Oncology Department
Tianjin Medical university Cancer Institute – Tianjin, China
Serglycin is a Theranostic Target in Nasopharyngeal
Carcinoma That Promotes Metastasis
Chao-Nan (Miles) Qian, MD, PhD,
Professor
Sun Yet-Sen University Cancer Center – Guangzhou, China
Collaboration Discussion
19